JARID1 Histone Demethylases: Emerging Targets in Cancer. [PDF]
Harmeyer KM +3 more
europepmc +1 more source
Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells. [PDF]
Romani M +4 more
europepmc +1 more source
Histone demethylases control root elongation in response to stress-signaling hormone abscisic acid. [PDF]
Wu J, Yamaguchi N, Ito T.
europepmc +1 more source
KDM5 histone demethylases repress immune response via suppression of STING. [PDF]
Wu L +23 more
europepmc +1 more source
Crosstalk between epigenetics and metabolism-Yin and Yang of histone demethylases and methyltransferases in cancer. [PDF]
Filipp FV.
europepmc +1 more source
The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance.
Agger K +5 more
europepmc +1 more source
Small Molecule Inhibitors of KDM5 Histone Demethylases Increase the Radiosensitivity of Breast Cancer Cells Overexpressing JARID1B. [PDF]
Pippa S +11 more
europepmc +1 more source
Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases. [PDF]
Li X +4 more
europepmc +1 more source
Role of Histone Demethylases in Cardiomyocytes Induced to Hypertrophy. [PDF]
Rosales W +4 more
europepmc +1 more source
Related searches:
Inhibitors of histone demethylases
Bioorganic and Medicinal Chemistry, 2011Methylated lysines are important epigenetic marks. The enzymes involved in demethylation have recently been discovered and found to be involved in cancer development and progression. Despite the relative recent discovery of these enzymes a number of inhibitors have already appeared.
Rasmus Prætorius Clausen +2 more
exaly +4 more sources

